Business · 18/06/1998Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance for Topical Dermatological Drug Products
Summary
The FDA is seeking public comments on a new draft guidance that provides recommendations for bioavailability and bioequivalence studies for topically applied dermatological drug products, applicable to NDA and ANDA submissions.